We found that PGK1 mRNA level was significantly associated with progressive pathologic TNM stage in breast carcinoma (BRCA), CESC, liver hepatocellular carcinoma (LIHC), and lung adenocarcinoma (LUAD) (Fig. 2a). This evidence concerns the gene PGK1 and breast carcinoma.